Stock Performance and Market Context
On 4 Mar 2026, Trident Texofab Ltd opened sharply lower at Rs.67.74, reflecting a day’s loss of 4.99%. The stock has been on a continuous downward trajectory, falling for 21 consecutive sessions and underperforming its sector by 2.12% today. This decline contrasts with the broader market’s mixed performance, where the Sensex, despite opening 1,710.03 points lower, managed a partial recovery to trade at 78,795.19, down 1.8% overall.
The stock’s current price is well below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum. In comparison, the Garments & Apparels sector itself has seen a decline of 2.95% today, indicating sector-wide pressures but with Trident Texofab underperforming even this benchmark.
Long-Term Price and Return Analysis
Over the past year, Trident Texofab Ltd has delivered a negative return of 60.88%, a stark contrast to the Sensex’s positive 7.96% gain during the same period. The stock’s 52-week high was Rs.379, highlighting the extent of the recent price erosion. This prolonged depreciation reflects a combination of factors affecting the company’s valuation and investor sentiment.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Financial Metrics and Fundamental Assessment
Trident Texofab’s financial profile reveals several areas of concern that have contributed to the stock’s subdued performance. The company’s Return on Capital Employed (ROCE) stands at a modest 6.88%, indicating limited efficiency in generating returns from its capital base. This figure is below industry averages and reflects challenges in sustaining profitability.
Debt servicing capacity is another critical factor, with a high Debt to EBITDA ratio of 6.83 times. This elevated leverage ratio suggests increased financial risk and pressure on cash flows, which may weigh on investor confidence and valuation multiples.
Quarterly results for December 2025 showed net sales at Rs.25.74 crore, the lowest recorded in recent periods, signalling subdued revenue momentum. This flat sales performance aligns with the broader trend of underperformance both in the near term and over longer horizons.
Comparative Performance and Valuation
In addition to the one-year return of -60.88%, Trident Texofab has underperformed the BSE500 index over the last three years, one year, and three months, underscoring persistent challenges in maintaining competitive growth and market positioning.
Despite these headwinds, the company’s valuation metrics present a nuanced picture. With a ROCE of 7.4 and an Enterprise Value to Capital Employed ratio of 1.6, the stock is trading at a discount relative to its peers’ historical valuations. This valuation gap reflects market caution but also indicates that the stock is priced below typical sector multiples.
Profitability has shown some improvement, with profits rising by 122.5% over the past year. The company’s Price/Earnings to Growth (PEG) ratio stands at 0.6, suggesting that earnings growth is not fully reflected in the current share price.
Shareholding and Market Grade
The majority of Trident Texofab’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The stock currently holds a Mojo Score of 23.0 and has been assigned a Mojo Grade of Strong Sell as of 3 Feb 2026, an upgrade from the previous Sell rating. The Market Cap Grade is 4, indicating a relatively modest market capitalisation within its sector.
Trident Texofab Ltd or something better? Our SwitchER feature analyzes this micro-cap Garments & Apparels stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Environment
The Garments & Apparels sector has experienced a decline of 2.95% today, reflecting broader pressures within the industry. Trident Texofab’s sharper fall relative to the sector highlights company-specific factors exacerbating the downtrend.
Meanwhile, other indices such as NIFTY Realty and S&P BSE Realty also hit new 52-week lows today, indicating pockets of weakness across different market segments. The Sensex remains below its 50-day moving average, although the 50DMA itself is above the 200DMA, suggesting mixed technical signals for the broader market.
Summary of Key Price and Performance Indicators
To summarise, Trident Texofab Ltd’s stock has reached Rs.67.74, its lowest level in the past year, after a sustained period of decline. The stock’s performance metrics, including a 21-day consecutive fall and a 65.81% loss in returns during this period, underscore the extent of the downward pressure. The company’s financial ratios and recent sales figures provide context for this trend, while valuation metrics indicate the stock is trading at a discount relative to peers.
Investors and market participants will note the stock’s current standing within the Garments & Apparels sector and its relative underperformance compared to broader indices. The combination of financial leverage, subdued sales, and modest returns on capital employed contribute to the stock’s current valuation and market sentiment.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
